Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis

Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis

Fabiola Atzeni,1 Antonio Carriero,2,3 Laura Boccassini,4 Salvatore D’Angelo2 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy; 2Rheumatology Institute of Lucania (IReL), Rheumatology Department of Lucania, San Carlo Hospital of Pot...

Full description

Bibliographic Details
Main Authors:	Atzeni F, Carriero A, Boccassini L, D'Angelo S
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-05-01
Series:	ImmunoTargets and Therapy
Subjects:	spondyloarthritis ankylosing spondylitis non radiographic axial spondyloarthritis axial spondyloarthritis anti-tnf drugs anti-il17 drugs interleukin 17
Online Access:	https://www.dovepress.com/anti-il-17-agents-in-the-treatment-of-axial-spondyloarthritis-peer-reviewed-fulltext-article-ITT

Similar Items

Ankylosing spondylitis and non-radiographic axial spondyloarthritis: Two stages of disease?
by: D G Rumyantseva, et al.
Published: (2017-05-01)

A single center experience: physician related diagnostic delay and demographic and clinical differences between patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis
by: Ulutaş Firdevs, et al.
Published: (2021-09-01)

An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis
by: Paccou J, et al.
Published: (2016-07-01)

Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum
by: Francisca Sivera, et al.
Published: (2023-05-01)

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
by: Raphael Micheroli, et al.
Published: (2017-07-01)

Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis
by: V. I. Mazurov, et al.
Published: (2021-01-01)

Progression of sacroiliitis in men and women according to the cohort of early axial spondyloarthritis (CORSAR) over 3 years of follow-up
by: D. G. Timokhina, et al.
Published: (2021-12-01)

IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
by: Dominique Baeten, et al.
Published: (2021-02-01)

No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors
by: Hua Zhang, et al.
Published: (2022-02-01)

COMPARATIVE ANALYSIS OF MAIN CLINICAL MANIFESTATIONS IN MALES AND FEMALES WITH EARLY AXIAL SPONDYLOARTHRITIS
by: D. G. Rumyantseva, et al.
Published: (2019-09-01)

Korean treatment recommendations for patients with axial spondyloarthritis
by: Mi Ryoung Seo, et al.
Published: (2023-09-01)

Disease activity and two-year sacroiliac joint changes according to instrumental study findings in a CoRSAr cohort of patients with early axial spondyloarthritis
by: Sh. Erdes, et al.
Published: (2019-05-01)

Achievement of clinical-laboratory and ASAS-partial remission in patients with early axial spondyloarthritis according to the ESAC cohort at the 3rd year of follow-up
by: Daria G. Timokhina, et al.
Published: (2022-06-01)

Axial Spondyloarthritis: An Evolving Concept
by: Nelly Ziadé
Published: (2015-07-01)

Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials
by: Damien Roche, et al.
Published: (2021-07-01)

Efficacy and safety of a new original interleukin 17A inhibitor in the treatment of patients with active ankylosing spondylitis: results of a basic (BCD-085-3/AILAS) and extended (BCD-085-3ext/AILAS-II) phase II clinical trial
by: Sh. Erdes, et al.
Published: (2019-12-01)

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

The Effect of Two Years of Secukinumab Treatment on Bone Metabolism in Patients with Radiographic Axial Spondyloarthritis: Results from Daily Clinical Practice
by: Siderius M, et al.
Published: (2023-12-01)

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
by: Philip C. Robinson, et al.
Published: (2019-02-01)

COMPARATIVE EVALUATION OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
by: I. А. Cherentsova, et al.
Published: (2016-09-01)

ASSESSMENT OF COXITIS PROGRESSION IN EARLY AXIAL SPONDYLOARTHRITIS
by: E. M. Agafonova, et al.
Published: (2020-04-01)

Management of Axial Spondyloarthritis – Insights into Upadacitinib
by: Braun J, et al.
Published: (2022-10-01)

Different Therapeutic Response to Anti-TNF Drugs in Patients with Axial Spondyloarthritis Depending on Their Clinical Profile: An Unsupervised Cluster Analysis
by: Carmen Priego-Pérez, et al.
Published: (2024-03-01)

DRAFT «ASPINE» MOBILE APPLICATION FOR PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS
by: D. G. Rumiantceva, et al.
Published: (2018-01-01)

Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis
by: I Z Gaĭdukova, et al.
Published: (2014-12-01)

A NEW CONCEPT OF SPONDYLOARTHRITIS: A COMPROMISE BETWEEN ASAS AND GRAPPA?
by: Sh. F. Erdes
Published: (2018-01-01)

Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort
by: Regula Neuenschwander, et al.
Published: (2020-10-01)

Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial
by: Désirée van der Heijde, et al.
Published: (2018-03-01)

Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis
by: I Z Gaydukova, et al.
Published: (2015-03-01)

Etanercept in axial spondyloarthritis – treatment efficacy
by: I. Z. Gaydukova, et al.
Published: (2022-03-01)

THE EVOLUTION OF AXIAL SPONDYLOARTHRITIS DURING 12-MONTH FOLLOW-UP STUDY OF A CORSAR COHORT
by: Sh. F. Erdes, et al.
Published: (2016-09-01)

Undifferentiated spondyloarthritis is more frequently seen in women than in men
by: Sukran Erten, et al.
Published: (2015-01-01)

Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis
by: Liudan Tu, et al.
Published: (2021-07-01)

Inflammatory and post-inflammatory lesions in the sacroiliac joints and lumbar spine according to magnetic resonance imaging in patients with early axial spondyloarthritis
by: D. G. Rumyantseva, et al.
Published: (2019-03-01)

Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis
by: Sizheng Steven Zhao, et al.
Published: (2019-07-01)

Biomarkers for Diagnosis of Axial Spondyloarthritis, Disease Activity, Prognosis, and Prediction of Response to Therapy
by: Walter P. Maksymowych
Published: (2019-03-01)

Advices for diagnostics of ankylosing spondylitis/axial spondyloarthritis: A review
by: Nikolay V. Bunchuk, et al.
Published: (2023-11-01)

REMISSION IN AXIAL SPONDYLOARTHRITIS: DEFINITION AND EVALUATION TOOLS (RECOMMENDATIONS OF THE SPONDYLOARTHRITIS STUDY GROUP OF EXPERTS, ALL-RUSSIAN PUBLIC ORGANIZATION «THE ASSOCIATION OF RHEUMATOLOGY OF RUSSIA»)
by: I. Z. Gaidukova, et al.
Published: (2018-03-01)

Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
by: Jonas Sagard, et al.
Published: (2022-02-01)

Low bone mineral density predicts the formation of new syndesmophytes in patients with axial spondyloarthritis
by: Hyoung Rae Kim, et al.
Published: (2018-10-01)